Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]

• Main Authors: Novakovic D (Author), Feligioni M (Author), Scaccianoce S (Author), Caruso A (Author), Piccinin S (Author), Schepisi C (Author), Errico F (Author), Mercuri NB (Author), Nicoletti F (Author), Nisticò R (Author)
• Format: Book
• Published: Dove Medical Press, 2014-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Novakovic D, Feligioni M, Scaccianoce S, et al. Drug Des Devel Ther. 2013;7:1359–1364.On page 1362, left hand column, last sentence under Functional studies:The effects of gantenerumab on cognitive assessment in the Morris water maze test were inconclusive, as both wild-type and transgenic...